After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
DGX belongs to the Healthcare sector of the NYSE while operating in the Diagnostics & Research industry. The current market capitalization of Quest Diagnostics, Inc is $18.87B. A total of 1.09 million shares were traded on the day, compared to an average of 1.14M shares.
In the most recent transaction, KUPPUSAMY KARTHIK bought 8,269 shares of DGX for 167.40 per share on Jul 30 ’25. In a previous transaction on May 12 ’25, DELANEY MARK E sold 874 shares at 175.72 per share. DGX shares that SVP & Chief Commercial Officer owns now total 8,372.
Among the insiders who sold shares, DELANEY MARK E disposed of 874 shares on May 13 ’25 at a per-share price of $175.31. This resulted in the SVP & Chief Commercial Officer holding 7,498 shares of DGX after the transaction. In another insider transaction, DELANEY MARK E bought 874 shares at $175.31 per share on May 13 ’25.
Dividend
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Quest Diagnostics, Inc pays an annual dividend of $3.10, resulting in a dividend yield of 1.84%, and it has a price to earnings (P/E) ratio of 20.18.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, DGX has a high of $182.38 and a low of $140.71.
As of this writing, DGX has an earnings estimate of $2.51 per share for the current quarter. EPS was calculated based on a consensus of 14.0 estimates, with a high estimate of $2.57 per share and a lower estimate of $2.48.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. DGX’s latest balance sheet shows that the firm has $872.00M in Cash & Short Term Investments as of fiscal 2021. There were $4.77B in debt and $1.75B in liabilities at the time. Its Book Value Per Share was $64.54, while its Total Shareholder’s Equity was $6.56B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
